IGC Pharma
IGC
#10699
Rank
S$33.08 M
Marketcap
S$0.32
Share price
1.59%
Change (1 day)
-41.29%
Change (1 year)
IGC Pharma, Inc. (formerly India Globalization Capital, Inc.) is a clinical-stage pharmaceutical company focused on developing advanced treatments for diseases, with a primary focus on Alzheimer's disease and other neurological conditions.

Earnings for IGC Pharma (IGC)

Earnings in 2026 (TTM): -S$8.4 Million

According to IGC Pharma's latest financial reports the company's current earnings are S$1.18 Million. In 2025 the company made an earning of -S$6.85 Million, an increase over its 2024 earnings that were of -S$11.29 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for IGC Pharma from 2006 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$8.4 Million22.73%
2025 -S$6.85 Million-39.35%
2024 -S$11.29 Million-37.72%
2023 -S$18.12 Million1.19%
2022 -S$17.91 Million21.96%
2021 -S$14.69 Million27.13%
2020 -S$11.55 Million57.16%
2019 -S$7.35 Million85.47%
2018 -S$3.97 Million52.76%
2017 -S$2.6 Million-16.23%
2016 -S$3.1 Million-28.75%
2015 -S$4.35 Million-19.59%
2014 -S$5.41 Million6.79%
2013 -S$5.07 Million-9.47%
2012 -S$5.59 Million-74.03%
2011 -S$21.53 Million119.78%
2010 -S$9.8 Million62.02%
2009 -S$6.05 Million74.39%
2008 -S$3.47 Million-313.12%
2007 S$1.62 M-35.94%
2006 S$2.53 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sterling Infrastructure
STRL
S$0.77 B-9,289.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Trinity Industries
TRN
S$0.96 B-11,587.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Granite Construction
GVA
-S$85.17 Million 915.47%๐Ÿ‡บ๐Ÿ‡ธ USA